Teva Pharmaceutical Industries Newsroom

Teva Pharmaceutical Industries (NYSE:TEVA) Has A Somewhat Strained Balance Sheet

Simply Wall StDec 14 08:56 ET

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

BenzingaDec 13 14:10 ET

10 Health Care Stocks Whale Activity In Today's Session

BenzingaDec 11 12:35 ET

Teva Announces New Patient Access Program With Direct Relief to Provide Access to Inhalers for Uninsured Patients

GlobeNewswireDec 11 08:00 ET

Medincell Publishes Its Consolidated Half-year Financial Results

BusinesswireDec 10 11:45 ET

Press Release: Medincell Publishes Its Consolidated Half-year Financial Results

Dow JonesDec 10 11:45 ET

Unusual Options Activity: PFE, HSY and Others Attract Market Bets, PFE V/OI Ratio Reaches 167.1

Moomoo NewsDec 6 11:30 ET

Teva Pharmaceutical to Divest Japanese Venture to JKI

MT NewswiresDec 6 03:31 ET

Takeda Pharmaceutical: To Receive Y55B From Sale of 49% Stake in JV With Teva Pharmaceutical Industries

Dow JonesDec 5 21:17 ET

Teva Pharmaceutical Industries Ltd. Enters Agreement to Divest Teva-Takeda Business Venture in Japan to JKI Co., Ltd.

Quiver QuantitativeDec 5 18:10 ET

Teva Entered Into An Agreement With JKI Co. Established By The Fund Managed And Operated By Private Equity Firm J-Will Partners Co., Through Which JKI Will Acquire Teva-Takeda; The Agreement Is Aligned With Teva's Pivot To Growth Strategy To Focus Its...

BenzingaDec 5 18:03 ET

Teva Pharmaceuticals to Sell Japan Venture Teva-Takeda to JKI Co.

Dow JonesDec 5 18:01 ET

Express News | Teva Pharmaceutical Industries Ltd - Expects Divestiture Completion by 1 April 2025

ReutersDec 5 18:00 ET

Teva Pharmaceutical Industries Limited (TEVA) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript

Earnings Call TranscriptsDec 5 13:23 ET

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsDec 5 12:35 ET · Ratings

Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients

MT NewswiresDec 4 04:25 ET

Teva Shares Phase 3 SPACE Trial Results Highlighting The Efficacy And Safety Of AJOVY (Fremanezumab) In Preventing Episodic Migraine In Children And Adolescents

BenzingaDec 4 02:20 ET

Teva Pharmaceutical Industries Options Spot-On: On December 3rd, 64,730 Contracts Were Traded, With 820.19K Open Interest

Moomoo NewsDec 3 16:30 ET

Teva Pharmaceutical Industries Options Spot-On: On November 29th, 141.86K Contracts Were Traded, With 674.74K Open Interest

Moomoo NewsNov 29 16:30 ET

Unusual Options Activity: AMZN, TEVA and Others Attract Market Bets, AMZN V/OI Ratio Reaches 859.4

Moomoo NewsNov 29 13:30 ET